Filter by
Documents (30)
RSSShowing results 20 to 30
Priority Actions
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 August 2022, edition 5)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 July 2022, edition 4)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 June 2022, edition 3)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 May 2022, edition 2)
Key performance indicators (KPIs) to monitor the European clinical trials environment (31 January – 30 April 2022, edition 1)
Annex II - Guidance document on how to approach the protection of personal data and commercially confidential information while using the Clinical Trials Information System (CTIS) Version 1.1
Annex I - Guidance document on how to approach the protection of personal data and commercially confidential information while using the Clinical Trials Information System (CTIS) Version 1.1
Guidance document on how to approach the protection of personal data and commercially confidential information while using the Clinical Trials Information System (CTIS) Version 1.1
Highlighted
Q&A on the protection of commercially confidential information and personal data while using CTIS
Updated guidance is available for CTIS users on how to protect personal data and commercially confidential information. Version 1.4 includes question 3.4 on patient-facing document.
Summary report on targeted consultation on the implementation of the Clinical Trials Regulation (EU) No 536/2014
A report is available summarising the findings of a survey for sponsors who submitted trials under the CTR. The survey was conducted in 2022.
